一个机械稳定的受体-连接体柔性键在血管系统中很重要
Jongseong Kim1, Cheng-Zhong Zhang, Xiaohui Zhang
1Immune Disease Institute, Children's Hospital Boston and Department of Pathology, Harvard Medical School, 3 Blackfan Circle, Boston, Massachusetts 02115, USA.
Nature
|August 21, 2010
概括
·威尔布兰德因子 (VWF) 与血小板结合,形成一种抗力结合,对血液静止至关重要. 这项研究揭示了VWF-血小板结合的新型双态机制,在水力动力学力下增强其强度.
科学领域:
- 生物物理学的生物物理.
- 血液学 血液学 血液学
- 细胞力学 细胞力学
背景情况:
- 血液静止依赖于由·维勒布兰德因子 (VWF) 介导的血小板相互作用.
- 与血小板结合的VWF必须承受动脉小管中显著的水力动力学力.
- VWF突变导致·威勒布兰德病,这是一个出血障碍.
研究的目的:
- 为了研究VWF A1-GPIbalpha键的机械化学特性.
- 描述在流动下血小板粘附的抗力机制.
- 开发一种单分子方法来测量受体-连接体动力学.
主要方法:
- 单分子 (ReaLiSM) 试验中的受体连接体的发展.
- 重复测量VWF A1域与GPIbalpha结合的单个分子.
- 约束状态的强度依赖寿命和动力测量.
主要成果:
- VWF-GPIbalpha键表现出两个不同的强力-耐力状态 (柔性键).
- 第二个债券状态在10 pN时发生,显示寿命长20倍,抗力增加.
- 单分子数据与批量测量一致,验证了发现.
结论:
- VWF-GPIbalpha键具有力抵抗的机械化学专业化.
- 这种双态机制解释了在高流量条件下血小板塞的形成.
- 这些发现提升了对血液循环中的血静和血小板激活的理解.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cell-matrix's Response to Mechanical Forces
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue.
Anchoring junctions mechanically attach a cell to the...
Anchoring junctions mechanically attach a cell to the...
Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...

